A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension

Clinical trial NCT02277691 · COMPLETED

Trial details

NCT number: NCT02277691
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2014-11-07
Primary completion: 2016-04-25
Enrollment: 341

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.